Perrigo (PRGO) Other Working Capital Changes (2013 - 2026)
Perrigo (PRGO) reported Other Working Capital Changes of -$2.5 million for Q1 2026, down 400.0% year-over-year from $833333.3 in Q1 2025, and up 99.13% quarter-over-quarter from -$286.1 million in Q4 2025.
Perrigo (PRGO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Other Working Capital Changes data on file, last reported at -$2.5 million in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$2.5 million, down 400.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$28.2 million (down 150.36% YoY), and the FY2025 annual result was -$26.2 million, down 135.07% from the prior year.
- Other Working Capital Changes grew to -$2.5 million in Q1 2026 per PRGO's latest filing, from -$286.1 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $259.9 million in Q3 2025 and troughed at -$286.1 million in Q4 2025.
- A 5-year average of $4.6 million and a median of -$2.5 million in 2026 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 88000.0% in 2023 and fell as far as 3591.43% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$3.5 million in 2022, then sank by 3591.43% to -$129.2 million in 2023, then surged by 149.77% to $64.3 million in 2024, then plunged by 544.95% to -$286.1 million in 2025, then jumped by 99.13% to -$2.5 million in 2026.
- Business Quant data shows PRGO's Other Working Capital Changes at -$2.5 million in Q1 2026, -$286.1 million in Q4 2025, and $259.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -2.50 Mn |
| Mar 28, 2026 | -2.50 Mn |
| Dec 31, 2025 | -286.10 Mn |
| Dec 31, 2025 | -286.10 Mn |
| Sep 27, 2025 | 259.90 Mn |
| Sep 27, 2025 | 259.90 Mn |
| Jun 28, 2025 | 500,000.00 |
| Jun 28, 2025 | 500,000.00 |
| Mar 29, 2025 | -500,000.00 |
| Mar 29, 2025 | -500,000.00 |
| Dec 31, 2024 | 64.30 Mn |
| Dec 31, 2024 | 64.30 Mn |
| Sep 28, 2024 | -2.90 Mn |
| Sep 28, 2024 | -2.90 Mn |
| Jun 29, 2024 | -4.90 Mn |
| Jun 29, 2024 | -4.90 Mn |
| Mar 30, 2024 | 18.20 Mn |
| Mar 30, 2024 | 18.20 Mn |
| Dec 31, 2023 | -129.20 Mn |
| Dec 31, 2023 | -129.20 Mn |